MX168996B - Proceso para preparar productos de aloe y producto resultante - Google Patents

Proceso para preparar productos de aloe y producto resultante

Info

Publication number
MX168996B
MX168996B MX014542A MX1454289A MX168996B MX 168996 B MX168996 B MX 168996B MX 014542 A MX014542 A MX 014542A MX 1454289 A MX1454289 A MX 1454289A MX 168996 B MX168996 B MX 168996B
Authority
MX
Mexico
Prior art keywords
resulting product
aloe products
prepare aloe
prepare
products
Prior art date
Application number
MX014542A
Other languages
English (en)
Inventor
Bill H Mcanalley
Original Assignee
Carrington Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carrington Lab Inc filed Critical Carrington Lab Inc
Publication of MX168996B publication Critical patent/MX168996B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9794—Liliopsida [monocotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Sustainable Development (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

La presente invención se refiere a una composición de materia que comprende: un polímero liofilizado substancialmente no degradable de unidades lineales de B(1 - 4)-D-mannosilo, en donde los grupos acetilo entremezclados casualmente son ligado al polímero por medio de un átomo de oxígeno y en donde D-galactopiranosa esta ligada al polímero por medio de un eslabonamiento de D-galactopiranosa por cada setenta unidades de monómero, la composición está polidispersada con por lo menos 70 por ciento de polímeros que tienen un peso molecular mayor de 10,000 daltons.
MX014542A 1988-01-14 1989-01-13 Proceso para preparar productos de aloe y producto resultante MX168996B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/144,872 US4851224A (en) 1986-06-05 1988-01-14 Process for preparation of aloe products

Publications (1)

Publication Number Publication Date
MX168996B true MX168996B (es) 1993-06-16

Family

ID=22510513

Family Applications (1)

Application Number Title Priority Date Filing Date
MX014542A MX168996B (es) 1988-01-14 1989-01-13 Proceso para preparar productos de aloe y producto resultante

Country Status (12)

Country Link
US (1) US4851224A (es)
EP (1) EP0356484B1 (es)
JP (1) JP2832551B2 (es)
KR (1) KR930001062B1 (es)
CN (1) CN1034313A (es)
AT (1) ATE96032T1 (es)
AU (1) AU3060289A (es)
CA (1) CA1312860C (es)
DE (1) DE68910051T2 (es)
MX (1) MX168996B (es)
WO (1) WO1989006539A1 (es)
ZA (1) ZA889733B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5118673A (en) * 1982-05-07 1992-06-02 Carrington Laboratories, Inc. Uses of aloe products
US5308838A (en) * 1982-05-07 1994-05-03 Carrington Laboratories, Inc. Uses of aloe products
US5106616A (en) * 1988-01-14 1992-04-21 Carrington Laboratories, Inc. Administration of acemannan
CA1328074C (en) * 1988-09-01 1994-03-29 Shigenori Tanaka Horseshoe crab amebocyte lysate factor g inhibitor
KR0141685B1 (ko) * 1988-09-01 1998-07-01 야마따니 와따루 참게 아메보사이트 라이세이트 g 인자 활성화 저해제
JP2514102B2 (ja) 1990-06-13 1996-07-10 ユリカ株式会社 ユリ科アロエ属に属する植物の真空凍結乾燥体を利用した錠剤製品及びその製造方法
US5316768A (en) * 1990-12-28 1994-05-31 Murdock International Corporation Pharmaceutical compositions having antiviral activity against human cytomegalovirus
US5409703A (en) * 1993-06-24 1995-04-25 Carrington Laboratories, Inc. Dried hydrogel from hydrophilic-hygroscopic polymer
US5902796A (en) * 1995-09-22 1999-05-11 Carrington Laboratories, Inc. Bioactive factors of aloe vera plants
US6929807B1 (en) * 1996-08-09 2005-08-16 Mannatech, Inc. Compositions of plant carbohydrates as dietary supplements
US5824659A (en) * 1996-09-04 1998-10-20 Board Of Regents, The University Of Texas System Cytoprotective oligosaccharide from Aloe preventing damage to the skin immune system by UV radiation
US6303584B1 (en) 1996-11-20 2001-10-16 The University Of Montana Water soluble lipidated arabinogalactan
WO1999019505A1 (en) 1997-10-10 1999-04-22 Univera Pharmaceuticals, Inc. Process for the preparation of immunomodulatory polysaccharides from aloe
US7022683B1 (en) 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
CN1088372C (zh) * 1998-11-24 2002-07-31 成都赛维芦荟制品有限公司 保鲜芦荟片的制备方法
US6630152B2 (en) * 1999-04-07 2003-10-07 Shen Wei (Usa), Inc. Aloe vera glove and manufacturing method
US6541678B2 (en) * 1999-09-27 2003-04-01 Brennen Medical, Inc. Immunostimulating coating for surgical devices
US7326404B2 (en) * 2000-05-31 2008-02-05 Vuksan Holdings Inc. Konjac-mannan and ginseng compositions and methods and uses thereof
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6884783B2 (en) * 2002-05-03 2005-04-26 Unigen Pharmaceuticals, Inc. 7-Hydroxy chromones as potent antioxidants
US7318374B2 (en) 2003-01-21 2008-01-15 Victor Guerrero Wire cloth coffee filtering systems
US7060304B2 (en) * 2003-04-16 2006-06-13 Access Business Group International Llc Skin whitening compositions containing black cohosh extract
US7999003B2 (en) * 2003-08-26 2011-08-16 Mannatech, Incorporated Antioxidant compositions and methods thereto
DE60326179D1 (de) * 2003-10-28 2009-03-26 Council Scient Ind Res Pflanzliche zubereitung zur behandlung von magengeschwüren
US7461587B2 (en) 2004-01-21 2008-12-09 Victor Guerrero Beverage container with wire cloth filter
WO2007043294A1 (ja) * 2005-09-22 2007-04-19 Morinaga Milk Industry Co., Ltd. 内臓脂肪蓄積抑制剤
CA2602066C (en) 2005-11-25 2014-02-11 Morinaga Milk Industry Co., Ltd. Aloe vera extract, method of producing aloe vera extract, and hyperglycemia improving agent
TWI454261B (zh) 2007-01-09 2014-10-01 Unigen Inc 作為治療劑之色酮類
CN101720226B (zh) 2007-05-11 2013-01-30 芦荟研究实验室公司 用于皮肤增强的芦荟制剂
WO2009043111A1 (en) * 2007-10-04 2009-04-09 Ultraceuticals R & D Pty Ltd Composition and method for dermal regeneration
AU2009303460B9 (en) * 2008-10-14 2014-12-18 Nerium Biotechnology, Inc. Process for extracting cardiac glycodides and compositions
US7833829B2 (en) * 2008-10-28 2010-11-16 Honeywell International Inc. MEMS devices and methods of assembling micro electromechanical systems (MEMS)
KR101086227B1 (ko) 2009-12-29 2011-11-23 주식회사 코리아나화장품 나도개감채 추출물을 유효성분으로 함유하는 화장료 조성물
US8604187B2 (en) * 2010-01-14 2013-12-10 North Texas Medical Associates Compositions and methods of aloe polysaccharides
EP2595643A4 (en) * 2010-07-23 2013-12-25 North Texas Medical Ass ANTIVIRAL PROPERTIES OF ALOEES AND TREATMENT OF ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS)
WO2012071253A1 (en) * 2010-11-23 2012-05-31 Fmc Corporation Process for isolating fucoidan and laminarin from live, harvested seaweed
US9327029B2 (en) 2011-05-05 2016-05-03 Celacare Technologies, Llc Antimicrobial silver hydrogel composition for the treatment of burns and wounds
EP4014983A1 (en) * 2015-04-13 2022-06-22 Capsulent Succulent extract and alginate combined solutions and products incorporating them
WO2018222902A1 (en) * 2017-06-02 2018-12-06 Extreme Fire Solutions, Llc Fire extinguishing systems and compositions and methods of use thereof
IT202300000402A1 (it) * 2023-01-13 2024-07-13 Omar SPREAFICO Sostanza comprendente aloe e procedimento per ottenere detta sostanza

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3362951A (en) * 1965-12-21 1968-01-09 Farkas Alexander Polysaccharide product derived from the juice of the aloe plant and methods for preparing same
US3360511A (en) * 1966-11-22 1967-12-26 Farkas Alexander Aloe polysaccharide composition and its preparation
US3892853A (en) * 1967-05-22 1975-07-01 Aloe 99 & 0 Inc Stabilized aloe vera gel and preparation of same
US3920816A (en) * 1967-12-29 1975-11-18 Vis Mediatrix Naturae Scient L Composition for treating respiratory diseases
US4178372A (en) * 1978-03-06 1979-12-11 Coats Billy C Hypoallergenic stabilized aloe vera gel
US4555987A (en) * 1983-07-22 1985-12-03 Tumlinson Larry N Method and apparatus for extraction of aloe vera gel
EP0328775B1 (en) * 1985-06-28 1993-10-20 Carrington Laboratories, Inc. Processes for preparation of aloe products, products produced thereby and compositions thereof

Also Published As

Publication number Publication date
CN1034313A (zh) 1989-08-02
ZA889733B (en) 1990-08-29
WO1989006539A1 (en) 1989-07-27
AU3060289A (en) 1989-08-11
EP0356484B1 (en) 1993-10-20
DE68910051T2 (de) 1994-05-05
ATE96032T1 (de) 1993-11-15
JP2832551B2 (ja) 1998-12-09
EP0356484A4 (en) 1990-02-05
US4851224A (en) 1989-07-25
DE68910051D1 (de) 1993-11-25
KR900700118A (ko) 1990-08-11
EP0356484A1 (en) 1990-03-07
KR930001062B1 (ko) 1993-02-15
CA1312860C (en) 1993-01-19
JPH02503094A (ja) 1990-09-27

Similar Documents

Publication Publication Date Title
MX168996B (es) Proceso para preparar productos de aloe y producto resultante
MX22641A (es) Proceso para producir polimeros pegajosos y producto obtenido
BR9000589A (pt) Processo para alvejamento de material lignocelulosico e produto obtido
AR227814A1 (es) Procedimiento para la preparacion de un producto para evitar la caida del cabello y para fomentar su crecimiento
AR227130A1 (es) Un producto detergente desodorante,procedimiento,para la preparacion del mismo y tela desodorante tratada con dicho producto
MX164382B (es) Producto cosmetico empacado
MX5220A (es) Procedimiento para la produccion de derivados de dicloroanilina y producto obtenido
IT7967277A0 (it) Cellulosica procedimento e impianto di trattamento in continuo di una materia
MX9204865A (es) Proceso para alcoxilacion de esteres y los productos elaborados.
MX19501A (es) Procedimiento para la preparacion de pirroles substituidos y productos obtenidos a partir del mismo.
BR9000838A (pt) Processo para dessecacao e abcisao de orgaos vegetais
MX18399A (es) Proceso mejorado para producir polibuteno y producto resultante
MX19479A (es) Procedimiento para producir polieteres que contienen oxido de isobutileno y producto obtenido mediante dicho procedimiento
BR8005299A (pt) Processo para a preparacao de 4-fluor-3-fenoxi benzil esteres, sua aplicacao e processo para a preparacao de produtos intermediarios
FI943671A0 (fi) Prosessi stabiloitujen, osittain dehydratoitujen aromaattisten kasvivalmisteiden tuottamiseksi ja tuotetut valmisteet
MX17107A (es) Procedimiento para la preparacion de tiazolo-(1,5)-benzodiazepinas y producto obtenido
PT81801B (pt) Processo para o tratamento da biomassa com vapor, produto assim obtido e sua utilizacao e reactor
BR7902859A (pt) Processo para a preparacao de 1,5-dimetilbicilo-(3,2,1)-octanol-8,e produtos obtidos
BR9001571A (pt) Produtos de mala direta e processo para formar um produto de mala direta
GB9010973D0 (en) Cellulosic product,process for the production thereof and uses thereof
IT1228578B (it) Procedimento ed impianto per la produzione di estratti secchi istantaneamente solubili da materiali naturali
ES2047456B1 (es) Composicion para la obtencion de un producto cosmetico y productos similares.
MX7458A (es) Procedimiento para la produccion de derivados de fenetilamina y producto obtenido
MX21001A (es) Procedimiento para la preparacion de derivados de amonoalquilbenceno substituidos y productos obtenidos a partir del mismo
ATA262187A (de) Zerkleinerungsvorrichtung zur behandlung eines heterogenen produkts